- New York State Sen. Liz Krueger is spearheading the push to legalise marijuana in the state after her bill failed to pass last year.
- Krueger leveled a stark warning against THC vape manufacturers at an exclusive Manhattan conference for cannabis investors.
- She also outlined how social justice efforts are crucial to passing cannabis reform in New York state. It points to deepening conflict between legalization advocates and so-called ‘corporate cannabis.’
- Click here for more BI Prime stories.
A New York state lawmaker delivered a stark warning to companies that make cannabis vapes, amid a spate of lung illnesses that have been tied to e-cigarettes.
State Sen. Liz Krueger, a Democrat who’s spearheading the push to legalise marijuana in the state, warned an audience of cannabis investors, family offices, and industry executives that they need to make sure their devices are safe, or risk being pulled from the market.
“If you’re in the vaping business, figure out how to make sure it’s not dangerous or you probably will be regulated out of business,” Liz Krueger, a Democrat, said on Tuesday at the Cannabis Private Investment Summit in Manhattan. “And keep it away from kids, or you’ll definitely be regulated out of business.”
Her warning came the same day that New York Gov. Andrew Cuomo, also a Democrat, moved to ban the sale of all flavored e-cigarette cartridges in the state.
A recent spate of vaping-related illnesses has upped pressure on cannabis companies, though the illnesses haven’t been definitively linked solely to THC-containing cartridges. In addition, some users may have used both legal and illegal vapes containing CBD, THC, nicotine, or other substances.
THC is the compound in marijuana that’s responsible for its signature high, while cannabidiol, or CBD, is a non-psychoactive compound that may potentially be useful for a range of therapeutic applications.
‘It all depends on whether the governor wants to do it’
Krueger, along with her counterpart in the New York State House, Crystal Peoples-Stokes, pushed a cannabis legalization bill in Albany earlier this year. That bill, the Marijuana Regulation and Taxation Act (MRTA), failed to pass given what Krueger says is lukewarm support on the governor’s part.
“It all depends on whether the governor wants to do it,” Krueger said. “Otherwise it’s not going to become law.”
For her part, Krueger said her bill will be committed to an “agenda of social and restorative justice” for the communities that were most harmed by marijuana prohibition.
“We are very committed to making sure – with all due respect – this is not some giant five companies controlling marijuana sales in New York State, but rather small, independent startups,” said Krueger.
In practice, that would likely mean limiting the US cannabis giants, like, say the Curaleafs or MedMens of the world, to a limited number of licenses to cultivate or sell marijuana. It could also mean rolling out the legislation with different types of licenses, with a priority given to small businesses in communities of colour – and giving entrepreneurs the startup capital and technical assistance they need to run profitable businesses, Krueger said.
‘Would you limit Starbucks to three locations in New York City?’
David Feldman, a partner at the law firm Duane Morris who leads the cannabis practice, told Business Insider in an interview that while he agrees with Krueger’s bill in principle, there are some aspects he would change.
“Why limit MSOs [multi-state cannabis operators] to three dispensaries per licence? Would you limit Starbucks to three locations in New York City?” said Feldman. “Don’t hold it against big corporations just for being big.”
Feldman does agree that social justice is crucial to getting cannabis reform passed in New York. That being said, “capitalism and the free market should rule,” said Feldman.
“It’s impossible to reverse all the ills of the drug war, but we have the opportunity to do a lot of good,” said Feldman. “Social justice is important, but it’s not everything. Legislation is always about compromise.”
In Feldman’s view, smart cannabis companies should care about social justice efforts – and put their money where their mouth is – especially given the climate around cannabis legalization advocacy.
This brewing antagonism between so-called ‘corporate cannabis’ and legalization advocates is reflected at the federal level. A group of advocates, including the Drug Policy Alliance, Centre for American Progress, the ACLU, Human Rights Watch, and others called on House Speaker Nancy Pelosi to delay a vote on the SAFE Banking Act – which would give cannabis businesses access to commercial banking services, which they do not have – over concerns that the bill favours the cannabis industry while social justice issues are left out, Politico reports.
“I believe it’s in the best interests of 300 million Americans and 20 million New Yorkers that we have smart, rational regulation of the cannabis industry,” said Krueger to the audience of cannabis investors and executives. “We don’t want cartels, we don’t want organised crime, we don’t want it being this giant criminal justice nightmare.”
“But we also don’t believe in laissez-faire, anything you want,” Kruger added. “So it needs to be negotiated, and it needs to be doable.”
- Read more:
- From Pax Labs to Surterra Wellness, VCs have poured over $US1.6 billion into cannabis startups this year alone as investor interest in the burgeoning industry explodes
- Cannabis could become a $US60 billion industry in the US. That’s more than double the market for vitamins and supplements.
- Buzzy cannabis-delivery startup Eaze is looking to raise a new round that could value it at $US400 million
- A group of Wall Street veterans just raised $US250 million to chase down deals in the red-hot cannabis sector. Its CEO explains how it got Credit Suisse on board.
Business Insider Emails & Alerts
Site highlights each day to your inbox.